Release Date: 27/08/09 13:35 Summary: 2009 Annual Results Announcement Price Sensitive: No Download Document 57.65KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%